PMCB
vs
U
USBC
PMCB
Over the past 12 months, PMCB has underperformed USBC, delivering a return of -41% compared to the USBC's +599 859% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
PMCB
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
PharmaCyte Biotech Inc
NASDAQ:PMCB
|
0.9489
USD
|
|||||
|
U
|
US BioTec Inc
OTC:USBC
|
0.599959
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
PMCB, USBC
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
PharmaCyte Biotech Inc
Revenue
|
|||||||||||
|
U
|
US BioTec Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
PMCB, USBC
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
PharmaCyte Biotech Inc
NASDAQ:PMCB
|
|||||||||
|
U
|
US BioTec Inc
OTC:USBC
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
PMCB, USBC
Performance Gap
PMCB, USBC
Performance By Year
PMCB, USBC
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
